Thyroid Hormone Receptor Antagonists: From Environmental Pollution to Novel Small Molecules

Area of Science:

• Endocrinology
• Molecular Biology
• Pharmacology

Background:

• Thyroid hormone receptors (TRs) are crucial nuclear receptors regulating vital physiological processes like metabolism and growth.
• Hyperthyroidism, caused by excessive thyroid hormone production, leads to detrimental TR stimulation.
• Current hyperthyroidism therapies exist, but novel small molecule TR antagonists are needed.

Purpose of the Study:

• To provide an overview of novel small molecules designed or screened as TR antagonists.
• To explore potential new treatments for hyperthyroidism using TR antagonist activity.
• To discuss existing sources of TR antagonists, including drug side effects and environmental pollutants.

Main Methods:

• Review and analysis of novel small molecules with TR antagonist activity.
• Screening of compounds for TR antagonist properties.
• Discussion of existing drugs and environmental factors with TR antagonist effects.

Main Results:

• Identification of novel small molecules with TR antagonist activity.
• None of the identified compounds have progressed to clinical trials yet.
• Existing drugs and environmental pollutants can act as TR antagonists, potentially causing hypothyroidism.

Conclusions:

• Novel small molecules targeting TRs offer potential for hyperthyroidism treatment.
• Further development is required for these compounds to enter clinical trials.
• Awareness of TR antagonist properties in current drugs and environmental factors is crucial for patient health.